Non invasive chemical analysis at embryo scale
Annaida Technologies SA
Incorporated
06.08.2018Headquarters
LausanneSupport
Annaida Technologies SA has developed a groundbreaking device, EmbryoSpin, that performs microscopic Nuclear Magnetic Resonance ("µNMR") at a scale 10-fold better than existing technologies, enabling non invasive chemical analysis at the scale of a single human embryo. µNMR opens new global markets in assisted reproductive technology ("ART"), enabling non-invasive embryo viability screening for in vitro fertilization ("IVF"), as well as in biochemical research.
News
Annaida obtains undisclosed pre-series A funding (startupticker.ch)
ZKB Pionierpreis Technopark 2025: Die Nominierten (startupticker.ch)
Innosuisse funded 45 Start-up innovation projects (startupticker.ch)
Pushing at the boundaries of IT, in healthcare and beyond (startupticker.ch)
Tech4Eva draws global interest (startupticker.ch)
BAS members invested a 7-digit amount in start-ups in 2020 (startupticker.ch)
Cleantech startups run the W. A. de Vigier Top 10 award (startupticker.ch)
Ten Venture Leaders Life Sciences startups prepare for the Boston roadshow in November (startupticker.ch)
Annaida raises CHF1 million to improve In Vitro Fertilization (startupticker.ch)
W.A. de Vigier Award : Numerous Cleantech Startups in the Top 16 (startupticker.ch)
Swiss startups on the global radar (startupticker.ch)
The AIT Brazil, Colombia and India startups revealed (startupticker.ch)
EPFL Spinoffs win CHF 130?000 each in the Venture Kick finale (startupticker.ch)
Milestones news
Closed seed financing round
Additional team member
Closed pre-seed round